Pharmacologic management of spasticity in multiple sclerosis

Abstract

Spasticity is very common in people with multiple sclerosis (MS). It is estimated that between 40 and 60% of all patients are affected. It consists of an abnormal, velocity-dependent increase in the phasic and tonic stretch reflexes, due to an abnormal integration of the nervous system motor responses to sensory input. The cause of spasticity could be due… (More)
DOI: 10.1007/s10072-006-0648-1

Topics

1 Figure or Table

Slides referencing similar topics